Here , we investigated the low dose pharmacology of orexin receptor antagonist , SB-@ , on neuroendocrine , sympathetic nervous system , and behavioral responses to insulin-induced hypoglycemic stress , in @ healthy male subjects ( aged @-@ years ; BMI @-@ @ kg/m ( @ ) ) , using a randomized , double-blind , placebo-controlled , within-subject crossover design .